GB894810A - Aqueous pharmaceutical solutions containing anti-inflammatory steroids - Google Patents

Aqueous pharmaceutical solutions containing anti-inflammatory steroids

Info

Publication number
GB894810A
GB894810A GB27189/60A GB2718960A GB894810A GB 894810 A GB894810 A GB 894810A GB 27189/60 A GB27189/60 A GB 27189/60A GB 2718960 A GB2718960 A GB 2718960A GB 894810 A GB894810 A GB 894810A
Authority
GB
United Kingdom
Prior art keywords
saturated
bonded
double
ketone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27189/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB894810A publication Critical patent/GB894810A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Steroids of the general formula <FORM:0894810/IV (b)/1> wherein the 1 : 2 position is saturated or double-bonded, X is a hydrogen or halogen atom, R is lower (C1-6) alkyl and Z is a divalent hydrocarbon radical of less than 10 carbon atoms may be prepared by treating a compound of general <FORM:0894810/IV (b)/2> formula <FORM:0894810/IV (b)/3> in which the 1 : 2 position may be saturated or double-bonded and X and R have the above stated meanings with a polycarboxylic acid anhydride, e.g. succinic, maleic or phthalic anhydride. Alternatively, they may be partially esterified with a polycarboxylic acid, e.g. oxalic, malonic, succinic, glutaric, maleic, malic, tartaric, citramalic, citric, oxalacetic, phthalic, isophthalic, or terephthalic acid. The intermediate compounds of formula II above may be prepared by treating a compound of the general formula <FORM:0894810/IV (b)/4> wherein the 1 : 2 position is saturated or double-bonded and X is a hydrogen or halogen atom with a ketone, e.g. acetone, methyl-ethyl ketone, diethyl ketone or ethylamyl ketone. Examples include preparations of sodium and ammonium hemi-ester salts.ALSO:Clear, stable, aqueous compositions comprise a polyoxyethylene sorbitan mono-oleate non-ionic surfactant and an anti-inflammatory steroid hormone of the 11b -hydroxy-16a ,17a -di - (C1-6 alkyl) - substituted - methylenedioxy-21 - carboxyacyloxy - 4 - pregnene - 3,20 - dione class, e.g. a compound which may be represented by the general formula <FORM:0894810/VI/1> wherein the 1 : 2 position is saturated or double-bonded, X is a hydrogen or halogen atom, R is lower (C1-6) alkyl and Z is a divalent hydrocarbon radical of less than 10 carbon atoms. The compositions may be in forms suitable for topical application, e.g. to the ears, eye, nose and throat and for parenteral administration. Optionally they may also contain other water-soluble drugs, e.g. antibacterial agents, antibiotics, e.g. neomycin sulphate, and sulpha drugs; conventional buffers, preservatives and isotonicizers.
GB27189/60A 1959-10-05 1960-08-05 Aqueous pharmaceutical solutions containing anti-inflammatory steroids Expired GB894810A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US894810XA 1959-10-05 1959-10-05

Publications (1)

Publication Number Publication Date
GB894810A true GB894810A (en) 1962-04-26

Family

ID=22217888

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27189/60A Expired GB894810A (en) 1959-10-05 1960-08-05 Aqueous pharmaceutical solutions containing anti-inflammatory steroids

Country Status (1)

Country Link
GB (1) GB894810A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158055A (en) * 1973-08-17 1979-06-12 American Cyanamid Company Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
EP2941437A4 (en) * 2013-01-07 2016-08-17 Aciex Therapeutics Inc Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158055A (en) * 1973-08-17 1979-06-12 American Cyanamid Company Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
EP2941437A4 (en) * 2013-01-07 2016-08-17 Aciex Therapeutics Inc Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Similar Documents

Publication Publication Date Title
GB1059188A (en) Colour stable oxytetracycline compositions and process for preparing same
GB894810A (en) Aqueous pharmaceutical solutions containing anti-inflammatory steroids
GB847570A (en) Shampoo compositions
GB952972A (en) Improvements in or relating to the production of tetracycline compounds
GB1043149A (en) Novel steroidal oximino ethers and methods for their manufacture
US4868170A (en) Steriod lotion formulation
US2880138A (en) Anti-inflammatory steroid solutions
US3335055A (en) More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same
NO141394B (en) PROCEDURE FOR PREPARING A CLEAR, STABLE DISSOLUTION OF A CORTICOSTEROID PHOSPHATE SALT AND NEOMYCINE SULPHATE
JPS6333327A (en) Stabilized phenylephrine liquid agent
NO138808C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PREGNANIC ACID DERIVATIVES
US2720482A (en) Stabilized streptomycin solutions
GB761618A (en) Steroid hormone compositions
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
GB802005A (en) Improvements in or relating to 6-methyl steroid compounds
US2100054A (en) Anesthetic tannate
DE1053734B (en) Process for solubilizing and stabilizing tetracycline antibiotics
IE31885B1 (en) Reduction of corticosteroid side effects
IE811604L (en) 11-alpha-amino androstanes
DE2352910A1 (en) Aqueous PHARMACEUTICAL COMPOSITION
GB1490476A (en) 6-aminomethylated-3-oxygenated cholest-5-enes
GB1108758A (en) Substituted-17ª‡-buta-1&#39;,3&#39;-diynyl-steroids
GB889310A (en) Improvements in or relating to steroid compounds
GB894040A (en) Salts of kanamycin and therapeutic compositions containing the same
GB839376A (en) Steroid compounds and their preparation